Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories’ step down wholly owned subsidiary -- Dr. Reddy's Laboratories LLC, Russia (DRL LLC), has entered into a distribution agreement with Novartis Pharma LLC (Novartis Pharma) to sale and distribute the anti-diabetes products - Galvus and Galvus Met - leading brands among Dipeptidyl Peptidase-4 (DPP4) molecules having combined sales of around Rs 253 crore (around $30 million) as per IQVIA Moving Annual Total (MAT) March 2024, retail market, in Russia.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.